Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Invictus MD Strategies Corp. (V:GENE)

Business Focus: Alternative Medicine

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for GENE within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Nov 05, 2019 08:27 ET
INVICTUS PROVIDES UPDATE ON ACREAGE PHARMS LTD. AND AB LABORATORIES INC.
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Marc Ripa, Interim Chief Executive Officer and Chief Operating Officer of Invictus, is pleased to report that the Company’s wholly owned subsidiary...
Read full article
Oct 23, 2019 18:30 ET
INVICTUS AND AUTHENTIC BRANDS GROUP MUTUALLY AGREE TO TERMINATE LICENSE AGREEMENT
Vancouver, B.C., October 23, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) The Company  and ABG-HMX, LLC (“ABG”) have mutually agreed to an early termination of the license agreement dated...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
2.77
--
--
Price to Sales - TTM
2.05
12.25
9.79
Price to Book - most recent quarter
0.14
1.72
2.16
Price to Cash Flow per share - TTM
--
8.61
12.12
Price to Free Cash Flow per share - TTM
--
2.38
22.38
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Nov 15, 201937,436-226,829
Oct 31, 2019264,265147,054
Oct 15, 2019117,2119,883
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Invictus MD Strategies Corp is Canada-based company engaged in the field of alternative medicine. The Company is focused on two main verticals within the Canadian cannabis sector: Licensed Producers and AB Laboratories Inc. The Licensed Producers vertical, which is under the Access to Cannabis for Medical Purposes (ACMPR), comprises investment in Acreage Pharms Ltd, located in West-Central Alberta; AB Laboratories Inc vertical comprises investment in AB Laboratories Inc, located near Hamilton, Ontario, which has both its cultivation and sales license under ACMPR.

See business summary

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).

Twitter

Search (past week) for $GENE.CA GENE.V

  • No tweets found